Market Data
Market Cap₹10,336.94 Cr.
52W High₹799.35
Current Price₹692.35
52W Low₹513.4
Down from 52W High13.4 %
Face Value₹10
Performance
ROCE9.41 %
ROE1.71 %
EPS (TTM)₹0.92
EPS Prev Qtr₹0.15
EPS Last Year₹1.16
EBITDA Qtr₹51.84 Cr.
Book Value₹89
Financial Health
Debt/Equity0.68
Debt/Profit27.37
Total Assets₹3,922.53 Cr.
Promoter Holding64.21 %
Earning Power5.7 %
Valuation
Stock P/E310.47
Industry P/E40.99
Price to Book7.76
Price to Sales3.93
Graham Number₹66.91
Key Metrics
Face Value
₹10
About Healthcare Global Enterprises Ltd
Healthcare · Healthcare
Healthcare Global Enterprises Ltd is listed on NSE in the Healthcare / Healthcare sector. Face value ₹10. Market cap ₹10,336.94 Cr.
Price Chart
Strengths & Weaknesses
Strengths
- The company has a substantial market capitalization of ₹10,463.1 Cr, indicating a significant presence in the healthcare sector.
- The company maintains a healthy promoter holding of 64.21%, suggesting strong control and alignment of interests.
Weaknesses
- The company has a very high P/E ratio of 452.13, which may indicate that the stock is overvalued relative to its earnings.
- The Return on Equity (ROE) is low at 2.5%, suggesting inefficient use of equity capital to generate profits.
- The company has a notable debt-to-equity ratio of 0.68, indicating a moderate level of financial leverage which could pose risks in volatile market conditions.
- The Return on Capital Employed (ROCE) is relatively low at 9.41%, indicating that the company may not be efficiently utilizing its capital to generate profits.
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | - | 60.97 | ₹1,27,421.96 Cr | 0.23% | ₹2,172 Cr | - | ₹26,429.9 Cr | - | 22.05% | 0.6 |
| Max Healthcare Institute Ltd | - | 66.77 | ₹97,411.97 Cr | 0.2% | ₹1,457.4 Cr | - | ₹8,712.05 Cr | - | 14.38% | 0.27 |
| Manipal Health Enterprises Ltd | - | - | ₹94,970.23 Cr | - | - | - | - | - | - | 1.25 |
| Aster DM Quality Care Ltd | - | 121 | ₹65,183.66 Cr | 0.4% | ₹362.82 Cr | - | ₹4,876.03 Cr | - | 12.95% | 0.17 |
| Fortis Healthcare Ltd | - | 59.91 | ₹62,782.32 Cr | 0.12% | ₹1,070.21 Cr | - | ₹9,506.15 Cr | - | 13.34% | 0.29 |
| Global Health Ltd | - | 69.27 | ₹38,550.84 Cr | - | ₹552.33 Cr | - | ₹4,683.41 Cr | - | 21.87% | 0.1 |
| Narayana Hrudayalaya Ltd | - | 45.26 | ₹37,159.95 Cr | - | ₹816.55 Cr | - | ₹9,072.4 Cr | - | 13.65% | 1.07 |
| Dr Lal Pathlabs Ltd | - | 46.81 | ₹32,548.55 Cr | 1.26% | ₹546.3 Cr | - | ₹2,890.8 Cr | - | 29.55% | 0 |
| Krishna Institute of Medical Sciences Ltd | - | 150.24 | ₹32,180.9 Cr | - | ₹194.4 Cr | - | ₹4,212.5 Cr | - | 9.66% | 1.44 |
| Poly Medicure Ltd | - | 52.64 | ₹16,587.48 Cr | 0.21% | ₹312.92 Cr | - | ₹1,997.43 Cr | - | 15.07% | 0.06 |
| Dr Agarwals Health Care Ltd | - | 107.57 | ₹15,991.79 Cr | - | ₹185.1 Cr | - | ₹2,206.68 Cr | - | 16.46% | 0.08 |
| Vijaya Diagnostic Centre Ltd | - | 82.27 | ₹15,431.94 Cr | 0.13% | ₹187.49 Cr | - | ₹857.13 Cr | - | 36.21% | 0 |
| Syngene International Ltd | - | 68.32 | ₹15,167.87 Cr | 0.33% | ₹221 Cr | - | ₹3,600.2 Cr | - | 6.95% | 0 |
| Indegene Ltd | - | 36.68 | ₹14,769.29 Cr | 0.37% | ₹400.9 Cr | - | ₹3,812.8 Cr | - | 17.45% | 0 |
| Rainbow Childrens Medicare Ltd | - | 48.85 | ₹13,947.12 Cr | 0.25% | ₹290.28 Cr | - | ₹1,820.14 Cr | - | 27.05% | 0 |
| Molbio Diagnostics Ltd | - | - | ₹13,924.73 Cr | - | - | - | - | - | - | 0.35 |
| Park Medi World Ltd | - | 38.3 | ₹11,945.05 Cr | - | ₹296.75 Cr | - | ₹1,756.29 Cr | - | 19.17% | 0.11 |
| Metropolis Healthcare Ltd | - | 24.51 | ₹11,863.54 Cr | 0.87% | ₹202.82 Cr | - | ₹1,710 Cr | - | 19.8% | 0.01 |
| Yatharth Hospital & Trauma Care Services Ltd | - | 58.5 | ₹10,596.57 Cr | - | ₹174.45 Cr | - | ₹1,334.1 Cr | - | 11.7% | 0.14 |
| Healthcare Global Enterprises Ltd | - | 446.68 | ₹10,336.94 Cr | - | ₹33.26 Cr | - | ₹2,627.35 Cr | - | 9.41% | 0.68 |
Quarterly Results
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 646.85 | 633.07 | 652.33 | 695.1 |
| ↳ QoQ Growth | - | -2.1% | +3.0% | +6.6% |
| Expenses | 586.34 | 584.11 | 590.06 | 643.26 |
| Operating Profit | 60.51 | 48.96 | 62.27 | 51.84 |
| OPM % | 9.35% | 7.73% | 9.55% | 7.46% |
| Other Income | 2.62 | 2.47 | 13.07 | 12.13 |
| Interest | 43.62 | 44.78 | 42.7 | 39.87 |
| Depreciation | 62.8 | 60.65 | 62.81 | 70.42 |
| EBITDA | 123.31 | 109.61 | 125.08 | 122.26 |
| EBITDA Margin % | 19.06% | 17.31% | 19.17% | 17.59% |
| Profit Before Tax | 19.82 | -6.07 | 1.25 | 25.03 |
| Tax % | -4.24% | -30.15% | -223.2% | 34.24% |
| Net Profit | 20.66 | -7.9 | 4.04 | 16.46 |
| ↳ QoQ Growth | - | -138.2% | +151.1% | +307.4% |
| EPS | 1.16 | -0.68 | 0.15 | 0.92 |
Balance Sheet
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 139.42 | 149.303 |
| Reserves | 783.03 | 1182.667 |
| Borrowings | 1837.22 | 910.41 |
| Other Liabilities | 783.57 | 1680.15 |
| Total Liabilities | 3543.24 | 3922.53 |
| Fixed Assets | 1963.03 | 2461.618 |
| CWIP | 24.76 | 18.565 |
| Investments | 11.31 | 13.88 |
| Other Assets | 1544.14 | 1428.47 |
| Total Assets | 3543.24 | 3922.53 |
Cash Flows
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from Operating Activity | 317.109 | 347.087 |
| Cash from Investing Activity | -487.752 | -177.47 |
| Cash from Financing Activity | -42.438 | 240.676 |
| Net Cash Flow | -213.081 | 410.293 |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 63.78% | 63.77% | 64.21% | 64.21% |
| FIIs % | 3.59% | 3.22% | 2.75% | 2.74% |
| DIIs % | 18.37% | 18.3% | 18.9% | 19.2% |
| Public % | 10.41% | 11.2% | 10.79% | 10.83% |
| No. of Shareholders | 46,970 | 45,366 | 47,649 | 48,905 |
Major Shareholders (>1%)
- Hector Asia Holdings Ii Pte. Ltd.Promoter and Promoter Group54.27%
- B S AjaikumarPromoter and Promoter Group9.30%
- Nippon Life India Trustee Ltd-a/c Nippon India ElsPublic Shareholding5.88%
- Axis Mutual Fund Trustee Limited A/c Axis Mutual FundPublic Shareholding3.58%
As of 2026-06-30View all shareholders →